文献速递肾移植肾小球疾病

抗肾病蛋白抗体指导一例儿童原发性局灶节段性肾小球硬化患者的活体供肾移植

Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis.
PubMed 文献 · Kidney Int · 2025-05-16

本文报告一例患有原发性局灶节段性肾小球硬化(pFSGS)的青少年在活体供肾移植前,通过监测并有效清除抗肾病蛋白(nephrin)抗体,移植后随访超过一年移植肾功能良好且无白蛋白尿。抗体采用ELISA、Western blot和免疫沉淀法检测,并发现其与另一种裂孔隔膜蛋白NEPH3(filtrin)存在交叉反应。

要点

  • 移植前使用利妥昔单抗和重复治疗性血浆置换可有效且持久降低抗肾病蛋白抗体。
  • 移植后随访超过一年,移植肾功能保持良好且无白蛋白尿。
  • 抗肾病蛋白抗体与NEPH3(filtrin)存在交叉反应。

主要发现

  • 移植前使用利妥昔单抗和重复治疗性血浆置换,有效且持久降低了抗肾病蛋白抗体。
  • 移植后随访超过一年,移植肾功能保持良好且无白蛋白尿。
  • 进一步分析显示抗体与NEPH3(filtrin)存在交叉反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Disease recurrence after kidney transplantation (KTx) remains a major challenge in patients with primary focal segmental glomerulosclerosis (pFSGS). Antibodies targeting the slit diaphragm protein nephrin have been identified in patients with early disease recurrence. Here, we describe monitoring and effective pre-transplant elimination of anti-nephrin antibodies in an adolescent with pFSGS prior to living-donor KTx. METHODS: Anti-nephrin antibodies were assessed in pre- and post-transplant serum samples by ELISA, Western blot and immunoprecipitation using three different nephrin proteins. RESULTS: Pre-transplant treatment including rituximab and repetitive therapeutic plasma exchanges resulted in effective and sustainable reduction of anti-nephrin antibodies. Allograft function has remained excellent without albuminuria over a follow-up of more than one year. Further analysis showed that the antibodies were cross-reactive with NEPH3 (filtrin), another key slit diaphragm protein. CONCLUSIONS: Monitoring and pre-transplant elimination of anti-slit diaphragm antibodies may become a standard, personalized approach in patients with pFSGS requiring KTx.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Habbig S, Debiec H, Chedik M, et al. Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis. Kidney Int. 2025. PMID: 40383230. doi:10.1016/j.kint.2025.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。